Pnc Financial Services Group, Inc. Pacira Bio Sciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,980 shares of PCRX stock, worth $72,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,980
Previous 3,597
17.15%
Holding current value
$72,533
Previous $67,000
10.45%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$195 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$128 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$55.1 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$54.5 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$49.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.12B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...